On Saturday, the Biden Administration told hospitals that “certain COVID patients may qualify for treatment faster based on their RACE” (emphasis original). The Washington Free Beacon had a detailed look at the story earlier that day.
This writer first exposed the roots of de facto medical racism in several articles at American Thinker on November 25, 2020, and April 26, 2021. The practice of treating patients based on their race or ethnicity was new. Now it’s going national, thanks to Biden’s FDA.
As noted on Saturday’s Fox News: The Biden Administration says certain people are “high risk” and qualify for monoclonal antibodies and oral antivirals used to treat COVID-19 faster because of their “race or ethnicity.”
The Beacon’s headline and subheadline revealed the policy’s origins: The FDA’s racial rationing of COVID drugs FDA guidelines justify racial triage policies. At the time of writing, I noted: “Redress” is mentioned in nearly every federal department and program in President Biden’s 200-page COVID-19 plan (published on January 21, 2021). Biden established a COVID-19 Health Equity Task Force at HHS.
Biden’s preoccupation with race and health care dates back to the 2020 election. As I noted when Biden’s COVID-19 Task Force was announced, one of the panel’s co-chairs perfectly fits this new race preference: Marcella Nunez-Smith, M.D., grew up in the Virgin Islands and now works at Yale University School of Medicine. Dr. Nunez-Smith focuses on race, social justice, and identity politics in medicine. The Biden Administration’s racist medical policies have been institutionalized by administrative state fiat, thanks to the COVID-19 Plandemic’s power. The world’s leading medical journals, including the New England Journal of Medicine, have all gone “woke.” The NEJM has created a “Race and Medicine Collection” on its website, including the full text of numerous recent articles.